Loading...

PANACEABIO Panacea Biotec Ltd Other Situations Announcement

Pnc

PNCB

Panacea Biotec Ltd

(PANACEABIO)

2025 Announcement

Show Summary

Show Summary

Share Dematerialization

Adjuvant Commercialization

Financial Results Publication

Secretarial Auditor Appoint...

Annual Compliance Report

ChilRun Study Results

Shares Dematerialized

Shares Dematerialized Update

Compliance Certificate

Management Change

Director Change

Director Change

Price Movement Clarification

Shares Dematerialized

Postal Ballot Notice

Financial Results Publication

Directorate Change

Management Changes

Leadership Change

Demat Report January 2025

Court Ruling Update

Share Dematerialization Update

Compliance Certificate

Management Change

Further Investment

UNICEF Order Award

Management Change

Shares Dematerialized Update

Postal Ballot Notice

Financial Results Released

Management Changes

Director Appointment

Share Dematerialization

Director Passing

Reclassification Application

Compliance Confirmation

Share Dematerialization Update

Auditor Appointment

Auditor Appointment

Lawsuit Settlement

KYC Compliance Reminder

Loan for Expansion

Demat Status Update

Annual Meeting Notice

Email Registration Notice

GST Demand Order

Financial Results Published

Auditor Resignation

DengiALL Trials Start

Auditor Appointment

Reclassification Update

Reclassification Request

Compliance certificate subm...

Demat Status Report

Arbitration Request

Management Change

Incorporation of Subsidiary

Demat Status Report

Financial Results Publication

Compliance Submission

Reclassification Withdrawal

Shares dematerialized

Senior Management Personnel...

Resignation Announcement

Certification Compliance

Demat Status Report

Compliance Certification

Certificate Issued

Directorate Change

Publication of Notices

Shares Dematerialized

Financial Results Published

Financial Results and Direc...

Shares Dematerialized

FDA Inspection Update

Shares Dematerialized

Compliance Certificate Subm...

Product Launches, Registration

Shares Dematerialized

Financial Results

Shares Dematerialized

Launch of Generic Version

US FDA Inspection

Shares Dematerialized

Arbitration Proceeding

Advertisement publication

Re-Classification Application

Shares Dematerialized

Financial Statements

Reclassification

Reclassification of Promoters

Rights Offerings

Product Expansion

Share dematerialization

Financial Results Submission

Reminder Letters

Compliance Report Submission

Financial Reports

External Links:

Data:

In January 2025, Panacea Biotec Ltd. dematerialized a total of 6,10,92,525 shares, consisting of 5,27,25,112 shares in NSDL and 83,67,413 shares in CDSL, as per SEBI regulations.

AI Assistant

Panacea Biotec Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.